Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/57716
Full metadata record
DC FieldValueLanguage
dc.creatorJessica St. Louispt_BR
dc.creatorCaroline M. Vailpt_BR
dc.creatorPaul E. Gosspt_BR
dc.creatorMayra E. Ferreyrapt_BR
dc.creatorKathrin Strasser-Weipplpt_BR
dc.creatorChristina I. Heroldpt_BR
dc.creatorGilberto de Lima Lopespt_BR
dc.creatorDon S. Dizonpt_BR
dc.creatorKathleen M. Schmelerpt_BR
dc.creatorMarcela Del Carmenpt_BR
dc.creatorTom C. Randallpt_BR
dc.creatorBrittany L. Bychkovskypt_BR
dc.creatorAngélica Nogueira Rodriguespt_BR
dc.creatorAknar Freire de Carvalho Calabrichpt_BR
dc.date.accessioned2023-08-10T21:08:24Z-
dc.date.available2023-08-10T21:08:24Z-
dc.date.issued2016-02-15-
dc.citation.volume122pt_BR
dc.citation.issue4pt_BR
dc.citation.spage502pt_BR
dc.citation.epage514pt_BR
dc.identifier.doihttps://doi.org/10.1002/cncr.29813pt_BR
dc.identifier.issn0008-543Xpt_BR
dc.identifier.urihttp://hdl.handle.net/1843/57716-
dc.description.resumoCervical cancer (CC) is second most common cause of cancer in Latin America and is a leading cause of cancer mortality among women. In 2015, an estimated 74,488 women will be diagnosed with CC in Latin America and 31,303 will die of the disease. CC mortality is projected to increase by 45% by 2030 despite human papillomavirus (HPV) vaccination and screening efforts. In this setting, the goal was of the current study was to examine CC control efforts in Latin America and identify deficiencies in these efforts that could be addressed to reduce CC incidence and mortality. The authors found that HPV vaccination has been introduced in the majority of Latin American countries, and there is now a need to monitor the success (or shortcomings) of these programs and to ensure that these programs are sustainable. This topic was also reviewed in light of emerging data demonstrating that visual inspection with acetic acid and HPV DNA testing without Papanicolaou tests have efficacy from a screening perspective and are good alternatives to cytology-based screening programs. Overall, there is a need to build capacity for CC control in Latin America and the best strategy will depend on the country/region and must be tailored to meet the needs of the population as well as available resources.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE CLÍNICA MÉDICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofCancer-
dc.rightsAcesso Abertopt_BR
dc.subjectCâncer cervicalpt_BR
dc.subjectPapilomavírus humanopt_BR
dc.subjectAmérica Latinapt_BR
dc.subjectTriagempt_BR
dc.subjectVacinaçãopt_BR
dc.subject.otherNeoplasias do Colo do Úteropt_BR
dc.subject.otherPapillomavirus Humanopt_BR
dc.subject.otherVacinaçãopt_BR
dc.subject.otherTriagempt_BR
dc.titleCervical cancer control in latin america: a call to actionpt_BR
dc.typeArtigo de Periódicopt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
Cervical cancer control in Latin America A call to action pdfa.pdf4.19 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.